Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Allena Pharmaceuticals Inc (ALNA)

Allena Pharmaceuticals Inc (ALNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,156
  • Shares Outstanding, K 122,083
  • Annual Sales, $ 0 K
  • Annual Income, $ -48,660 K
  • 60-Month Beta 1.13
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.16
Trade ALNA with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.38
  • Most Recent Earnings -0.08 on 08/15/22
  • Next Earnings Date 08/23/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.05
  • Number of Estimates 1
  • High Estimate -0.05
  • Low Estimate -0.05
  • Prior Year -0.17
  • Growth Rate Est. (year over year) +70.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0580 +29.31%
on 09/06/22
0.1500 -50.00%
on 09/07/22
-0.0650 (-46.43%)
since 08/05/22
3-Month
0.0580 +29.31%
on 09/06/22
0.4400 -82.95%
on 06/29/22
-0.0373 (-33.21%)
since 06/07/22
52-Week
0.0580 +29.31%
on 09/06/22
1.1700 -93.59%
on 11/03/21
-1.0050 (-93.06%)
since 09/07/21

Most Recent Stories

More News
Allena Pharmaceuticals Announces New Meeting Date and New Record Date for Special Meeting to Approve Reverse Stock Split

NEWTON, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to...

ALNA : 0.0750 (+3.16%)
Allena Pharmaceuticals Announces Rescheduling of Special Meeting to Approve Reverse Stock Split

NEWTON, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to...

ALNA : 0.0750 (+3.16%)
Allena Pharmaceuticals Announces $2.8 Million Registered Direct Offering

NEWTON, Mass., May 04, 2022 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to...

ALNA : 0.0750 (+3.16%)
Allena Pharmaceuticals Provides Clinical and Corporate Update

ALLN-346, an orally administered enzyme in development for the treatment of hyperuricemia and gout, demonstrates a statistically significant reduction in...

ALNA : 0.0750 (+3.16%)
Versantis Appoints Mark Fitzpatrick, Seasoned Biotech Executive, as its New CEO

Versantis, a clinical-stage biotechnology company developing novel therapies for orphan liver and pediatric diseases, today announced the appointment of Mark J. Fitzpatrick as Chief Executive Officer (CEO)...

ALNA : 0.0750 (+3.16%)
After Plunging 19.7% in 4 Weeks, Here's Why the Trend Might Reverse for Allena Pharmaceuticals, Inc. (ALNA)

The heavy selling pressure might have exhausted for Allena Pharmaceuticals, Inc. (ALNA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall...

ALNA : 0.0750 (+3.16%)
Allena Pharmaceuticals, Inc. (ALNA) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Allena Pharmaceuticals, Inc. (ALNA) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions...

ALNA : 0.0750 (+3.16%)
Allena Pharmaceuticals (ALNA) Sees Hammer Chart Pattern: Time to Buy?

Allena Pharmaceuticals (ALNA) has been struggling lately, but the selling pressure may be coming to an end soon.

ALNA : 0.0750 (+3.16%)
Allena Pharmaceuticals to Participate in the Stifel 2021 Virtual Healthcare Conference

NEWTON, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage biopharmaceutical company deploying its novel...

ALNA : 0.0750 (+3.16%)
Allena Pharmaceuticals Reports Third Quarter 2021 Financial Results and Recent Corporate Progress

ALLN-346, a first-in-class, non-absorbed, orally administered enzyme in development for the treatment of hyperuricemia and gout in the setting of advanced...

ALNA : 0.0750 (+3.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Allena Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in developing and commercializing oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders primarily in the United States. The companys product candidate includes ALLN-177 and ALLN-346 which...

See More

Key Turning Points

3rd Resistance Point 0.2200
2nd Resistance Point 0.1850
1st Resistance Point 0.1300
Last Price 0.0750
1st Support Level 0.0400
2nd Support Level 0.0050
3rd Support Level N/A

See More

52-Week High 1.1700
Fibonacci 61.8% 0.7452
Fibonacci 50% 0.6140
Fibonacci 38.2% 0.4828
Last Price 0.0750
52-Week Low 0.0580

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar